Recursion Pharmaceuticals, Inc. (RXRX) NASDAQ

4.37

+0.19(+4.55%)

Updated at June 02 04:00PM

Currency In USD

Valuation

Market Cap1.85B
Enterprise Value1.37B
P/E Ratio-3.1
PEG Ratio0.47
Price/Sales Ratio29.55
Price/Book Ratio1.91
Enterprise/Revenue22.74
Enterprise/EBITDA-2.54

Fiscal Year

Fiscal YearDecember 31, 2024
Most Recent QuarterMarch 31, 2025

Profitability

Profit Margin-9.62
Operating Margin-9.61

Management Effectiveness

Return On Assets-0.44
Return On Equity-0.75

Income Statement

Revenue58.84M
Revenue/Share0.15
Gross Profit13.6M
EBITDA-426.72M
Net Income-463.66M
Diluted EPS-1.69

Balance Sheet

Total Cash500.45M
Total Cash/Share1.24
Total Debt92.91M
Total Debt/Equity0.1
Current Ratio4.11
Book Value Per Share2.32

Price History

52-Week Change-48.55
52-Week High12.36
52-Week Low3.79
Moving Average 50 Days5.07
Moving Average 200 Days6.52

Statistics

Average Volume20.59M
Shares Outstanding399.66M
% Held by Institutions75.54

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio0
Last Split FactorN/A
Last Split DateN/A